August 11, 2020

Volume X, Number 224

August 11, 2020

Subscribe to Latest Legal News and Analysis

August 10, 2020

Subscribe to Latest Legal News and Analysis

Department of Justice Takes Swift Action to Combat Coronavirus-Related Fraud

Since the Department of Justice announced on March 23 that it formed a national task force to combat Coronavirus Disease 2019 (COVID-19)-related crime, U.S. Attorneys’ Offices around the country have ramped up their efforts to team with federal, state, and local agencies to investigate and charge alleged hoarders, price-gougers, and fraudsters looking to profit from this national health emergency.

Pursuant to the Coronavirus Aid, Relief, and Economic Security (CARES) Act, signed into law on March 27, $2 trillion will be going to direct payments to individuals and loans for major industries and small businesses. This unprecedented infusion of dollars to businesses and individuals may open the door to an increased level of false claims and other fraud. As a result, federal prosecutors, the IRS, the SEC, and other federal and state agencies around the country have warned the public to be vigilant against bad actors and fraud schemes that may crop up during the health crisis.

There has already been evidence of testing and treatment scams; medical supply scams; and investment scams, where promotions styled as “research reports” make predictions that certain products or services of publicly traded companies can prevent or cure COVID-19, and that the stock of these companies will dramatically increase in value as a result. Attorney General William Barr has identified examples of some of the schemes that are expected, including:

  • individuals and businesses selling fake cures for COVID-19 online and engaging in other forms of fraud;
     
  • phishing emails from entities posing as the World Health Organization or CDC;  
                
  • malicious websites and apps that appear to share coronavirus-related information to gain and lock access to your devices until payment is received;
     
  • seeking “donations” for illegitimate or non-existent charitable organizations; and
     
  • medical providers obtaining patient information for COVID-19 testing and using the information to fraudulently bill for other tests and procedures.

In the aftermath of past emergencies, such as Hurricanes Katrina and Sandy and the 2008 financial crisis, there was also an upsurge in claims against government contractors and other entities that received federal emergency funds. Based on the enormity of the amount of money that is tapped to be pumped into the economy, the extent of fraud related to this pandemic may be extraordinary.

First Wave of Federal Charges Already Filed

On March 24, Deputy Attorney General Jeffrey Rosen released a memo that detailed the tools available to crack down on a slew of crimes related to the pandemic. The memo further advised federal authorities to work in concert with state and local law enforcement agencies in pursuing COVID-19-related cases. As a result, several U.S. Attorney’s Offices around the country have joined forces with federal, state, and local agencies to dedicate resources to their own COVID-19 fraud task forces.

One of the first enforcement actions against alleged coronavirus fraud occurred in Texas. The DOJ obtained a temporary restraining order against the website “coronavirusmedicalkit.com.” Prosecutors allege the site claimed to offer consumers access to vaccine kits from the WHO, although there are currently no vaccines for the disease.

The District of Columbia U.S. Attorney’s Office charged a Georgia man with wire fraud after he attempted to sell millions of nonexistent respirator masks to the federal government. The criminal complaint alleges that he made and caused to be made a series of fraudulent misrepresentations in an attempt to secure orders from the Department of Veterans Affairs for 125 million face masks and other personal protective equipment (PPE) that would have totaled over $750 million, which he was requesting to be paid upfront. Through a series of misrepresentations, the man claimed to act as a supplier who could quickly obtain the scarce PPE and supplies.

In California, a man was arrested on a federal criminal wire fraud charge alleging he solicited investments in a company he claimed would be used to market pills that would prevent coronavirus infections and an injectable cure for those already suffering from COVID-19. The complaint alleges that he claimed to have personally developed a “patent-pending cure” and a treatment that prevents coronavirus infection. In another California case, a British man was named in a criminal complaint that alleged he smuggled into the United States mislabeled drugs purported to be a treatment for those suffering from COVID-19. He was charged with a felony of introducing misbranded drugs into interstate commerce.

A Brooklyn man was charged with lying to federal agents about accumulating surgical masks, medical gowns, and other medical supplies, and then selling them at inflated prices. During questioning by FBI agents, he allegedly coughed in the direction of the agents, without covering his mouth, and then told the agents that he had coronavirus. He was subsequently arrested and charged with assaulting a federal officer.

* * *

 Companies receiving CARES or other government funding should consider what precautions may be necessary to protect against the risk of potential future liability, including under the False Claims Act. Now is the time to be vigilant about observing compliance processes and improving internal controls.

©2020 Greenberg Traurig, LLP. All rights reserved. National Law Review, Volume X, Number 107

TRENDING LEGAL ANALYSIS


About this Author

Matthew Cannon, Greenberg Traurig Law Firm, Chicago, Litigation Attorney
Shareholder

Matthew J. Cannon has almost two decades of criminal and civil litigation experience. He has served as the First Chair in numerous federal jury trials and has combined his courtroom skills, his experience as a federal prosecutor with the Department of Justice (DOJ), and his wide-ranging civil litigation skills into a practice that combines anti-corruption compliance work and litigation. Matt’s practice includes implementing and assessing anti-corruption compliance programs throughout the world, including programs focused on the Foreign Corrupt Practices Act (FCPA)...

312-456-1066
Daniel P. Filor Criminal Lawyer Greenberg Traurig Law Firm
Shareholder

Daniel P. Filor, a former Assistant U.S. Attorney for the Southern District of New York, focuses his practice on government investigations, securities fraud, antitrust law and white collar criminal defense. With both civil and criminal law experience, Daniel counsels clients on a wide variety of matters ranging from criminal fraud allegations to complex commercial litigation.

With more than a decade of experience in the U.S. Attorney’s Office, Daniel knows how governmental decision-making works, and draws on his experience to advise individual and organizational clients confronting criminal and civil allegations of misconduct. When courtroom advocacy is required, Daniel’s talents, attained from numerous criminal and civil trials, are invaluable.

Concentrations

  • White collar criminal defense
  • Government investigations
212-801-6758
Kyle R. Freeny Shareholder Anti-money laundering issues Bank Secrecy Act Anti-corruption, Foreign Corrupt Practices Act, Asset forfeiture, Foreign Agents Registration Act FARA, Government investigations,Compliance counseling
Shareholder

Kyle R. Freeny, a skilled trial attorney and former federal prosecutor for the Special Counsel’s Office and the Department of Justice (DOJ), Criminal Division’s Money Laundering and Asset Recovery Section (MLARS), focuses her practice on white collar criminal defense, government and internal investigations, and anti-money laundering (AML) and international corruption matters.

Kyle was one of 19 prosecutors selected by Robert S. Mueller III to conduct the high-profile investigation into alleged Russian election interference, coordination between Russian officials and the Trump...

202-331-3118
 Wendy J. Dickieson ASSOCIATE New York
Associate

Wendy J. Dickieson is a member of the Litigation Practice in Greenberg Traurig's New York office.

 

212-801-6445